DUPIXENT® (dupilumab) Sitemap for COPD

Skip to main content

For questions about financial assistance,
call 1-844-DUPIXENT, option 1 or
click to learn more

CHANGE CONDITION
Prescribing & Patient
Information
- PATIENT INFORMATION
- Patient Information - English
- Patient Information - Spanish
- PRESCRIBING INFORMATION
- Prescribing Information - English
- Prescribing Information - Spanish
- PRE-FILLED SYRINGE INSTRUCTIONS FOR USE
- 300 mg Syringe - English
- 300 mg Syringe - Spanish
- PRE-FILLED PEN INSTRUCTIONS FOR USE
- 300 mg Pen - English
- 300 mg Pen - Spanish
For Healthcare
Professionals
Copay
Offer
Patient
Brochure
Email
Sign Up
FOR U.S. RESIDENTS ONLY

What is
COPD?
About
DUPIXENT
- Results With DUPIXENT
PATIENT SUPPORT,
COST & SAVINGS
Taking
Dupixent
Resources
For Healthcare Professionals
Copay Offer
Patient Brochure
Email Sign Up

SITE MAP

DUPIXENT HOME
WHAT IS COPD?
ABOUT DUPIXENT
- Results With DUPIXENT
PATIENT SUPPORT, COST & SAVINGS
Taking Dupixent
Resources

Important Safety Information and Indication

Do not use if you are allergic to dupilumab or to any of the ingredients in DUPIXENT®.

Before using DUPIXENT, tell your healthcare provider about all your medical conditions, including if you:

have eye problems.
have a parasitic (helminth) infection.
are scheduled to receive any vaccinations. You should not receive a “live vaccine” right before and during treatment with DUPIXENT.
are pregnant or plan to become pregnant. It is not known whether DUPIXENT will harm your unborn baby.
- A pregnancy registry for women who take DUPIXENT during pregnancy collects information about the health of you and your baby. To enroll or get more information call 1-877-311-8972 or go to https://mothertobaby.org/ongoing-study/dupixent/.
are breastfeeding or plan to breastfeed. It is not known whether DUPIXENT passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Especially tell your healthcare provider if you are taking oral, topical, or inhaled corticosteroid medicines or have chronic obstructive pulmonary disease and also have asthma. Do not change or stop your other medicines, including corticosteroid medicine or other asthma medicine, without talking to your healthcare provider. This may cause other symptoms that were controlled by those medicines to come back.

DUPIXENT can cause serious side effects, including:

Allergic reactions. DUPIXENT can cause allergic reactions that can sometimes be severe. Stop using DUPIXENT and tell your healthcare provider or get emergency help right away if you get any of the following signs or symptoms: breathing problems or wheezing, swelling of the face, lips, mouth, tongue or throat, fainting, dizziness, feeling lightheaded, fast pulse, fever, hives, joint pain, general ill feeling, itching, skin rash, swollen lymph nodes, nausea or vomiting, or cramps in your stomach-area.
Eye problems. Tell your healthcare provider if you have any new or worsening eye problems, including eye pain or changes in vision, such as blurred vision. Your healthcare provider may send you to an ophthalmologist for an exam if needed.
Joint aches and pain. Some people who use DUPIXENT have had trouble walking or moving due to their joint symptoms, and in some cases needed to be hospitalized. Tell your healthcare provider about any new or worsening joint symptoms. Your healthcare provider may stop DUPIXENT if you develop joint symptoms.

The most common side effects in patients with chronic obstructive pulmonary disease include injection site reactions, common cold symptoms (nasopharyngitis), high count of a certain white blood cell (eosinophilia), viral infection, back pain, inflammation inside the nose (rhinitis), diarrhea, gastritis, joint pain (arthralgia), toothache, headache, and urinary tract infection.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of DUPIXENT. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Use DUPIXENT exactly as prescribed by your healthcare provider. It’s an injection given under the skin (subcutaneous injection). Your healthcare provider will decide if you or your caregiver can inject DUPIXENT. Do not try to prepare and inject DUPIXENT until you or your caregiver have been trained by your healthcare provider.

Please see accompanying full Prescribing Information including Patient Information.

Indication

DUPIXENT is a prescription medicine used with other medicines for the maintenance treatment of adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and a high number of blood eosinophils (a type of white blood cell that may contribute to your COPD). DUPIXENT is used to reduce the number of flare-ups (the worsening of your COPD symptoms for several days) and can improve your breathing. DUPIXENT is not used to relieve sudden breathing problems and will not replace an inhaled rescue medicine. It is not known if DUPIXENT is safe and effective in children with chronic obstructive pulmonary disease under 18 years of age.

Site Map
Legal Disclaimer Information

Questions or comments?
Contact Sanofi US or Regeneron Pharmaceuticals, Inc. or call 1-844-387-4936 to contact DUPIXENT MyWay®.

© 2024 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.
DUPIXENT® and DUPIXENT MyWay® are registered trademarks of Sanofi Biotechnology.

Sanofi US is hosting this website on behalf of Sanofi and Regeneron Pharmaceuticals, Inc.

Sanofi and Regeneron are industry partners, who are committed to handling personal data in ways that respect your privacy. Both companies may independently process your personal data to manage patient support programs and product marketing campaigns. Please refer to Regeneron's Privacy Notice and Sanofi's Privacy Policy and Cookies Policy for more information regarding processing of your personal data.

This DUPIXENT® (dupilumab) website is for U.S. healthcare professionals only. Click “continue” only if you are a U.S. healthcare professional.

US-DAS-1231(1)

Are you sure you want to leave?

Please note: By clicking on this link, you will be leaving this Sanofi-hosted US website and going to another, entirely independent website. Sanofi US and Regeneron provide these links as a service to their website visitors and users; however, they take no responsibility for the information on any website but their own.

Enter your email address and we will send you your requested resource.

Email Address Please provide a valid email address.

Success!

Your email is on its way. Be sure to check your inbox.

Rate your conversation

🙁 😐 😃 🤩

Thanks for the feedback!